Plerixafor
Product Specifications
Background
Plerixafor is a highly selective CXCR4 antagonist (IC50 = 20-130 nM) .1,2 Originally investigated as an HIV replication inhibitor.3 Plerixafor has been investigated for the treatment autoimmune diseases and various cancers.4 Clinically useful for the mobilization of hematopoietic stem cells in the treatment of blood cancers.
Conjugation
Unconjugated
Buffer
White solid
Storage Conditions
RT
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
